Price $32.76 |
Market Cap
360M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
9.28
|
P/S
158.58
|
Dividend %
-
|
|
P/CF
37.0
|
P/FCF
-
|
Op. Cash Flow
-11.7K
|
FCF
-1.1
|
|
Op. Margin
-695.30%
|
Net Margin
-614.70%
|
ROE
-33.90%
|
ROI
-5.10%
|
|
ROA
-15.20%
|
EPS Growth
-
|
Current Ratio
6.7
|
Debt/Equity
61.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $3.92 | - | - | 147.3M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $2.33 | - | - | 62.4M | Strong Buy |
| Assembly Biosciences Inc (ASMB) | $5.66 | - | - | 188.2M | Strong Buy |
| Boston Scientific Corporation (BSX) | $33.65 | - | - | 48.04B | Strong Buy |
| Elite Pharmaceuticals Inc (ELTP) | $0.05 | - | - | 55.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
